Loading...
VYNE Therapeutics Inc.
VYNE•NASDAQ
Healthcare
Biotechnology
$1.62
$0.25(18.25%)
VYNE Therapeutics Inc. (VYNE) Quarterly Earnings Reports & Financial Results
Analyze VYNE Therapeutics Inc.’s revenue, EPS, and earnings surprises to assess performance and investor sentiment over recent quarters.
Total Reports
0
Avg EPS
N/A
Avg Revenue
N/A
Beats Estimates
0 out of 0
Max EPS
N/A
Min EPS
N/A
Earnings Visualization
Visual comparison of VYNE Therapeutics Inc.’s actual vs. estimated earnings across recent quarters.
No data available
VYNE Therapeutics Inc. (VYNE) Quarterly Earnings Details
Detailed breakdown of VYNE Therapeutics Inc.’s earnings per share (EPS), revenue estimates vs. actuals, and earnings surprises by quarter.